Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 1
1996 4
1997 4
1998 5
1999 1
2000 4
2001 4
2002 2
2003 3
2004 6
2005 5
2006 9
2007 8
2008 10
2009 7
2010 9
2011 4
2012 8
2013 7
2014 7
2015 6
2016 7
2017 6
2018 14
2019 13
2020 12
2021 7
2022 11
2023 7
2024 6
2025 6
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean ciol m[Author] (171 results)?
Molecular and histological correlations in liver cancer.
Calderaro J, Ziol M, Paradis V, Zucman-Rossi J. Calderaro J, et al. Among authors: ziol m. J Hepatol. 2019 Sep;71(3):616-630. doi: 10.1016/j.jhep.2019.06.001. Epub 2019 Jun 10. J Hepatol. 2019. PMID: 31195064 Review.
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis.
Mózes FE, Lee JA, Selvaraj EA, Jayaswal ANA, Trauner M, Boursier J, Fournier C, Staufer K, Stauber RE, Bugianesi E, Younes R, Gaia S, Lupșor-Platon M, Petta S, Shima T, Okanoue T, Mahadeva S, Chan WK, Eddowes PJ, Hirschfield GM, Newsome PN, Wong VW, de Ledinghen V, Fan J, Shen F, Cobbold JF, Sumida Y, Okajima A, Schattenberg JM, Labenz C, Kim W, Lee MS, Wiegand J, Karlas T, Yılmaz Y, Aithal GP, Palaniyappan N, Cassinotto C, Aggarwal S, Garg H, Ooi GJ, Nakajima A, Yoneda M, Ziol M, Barget N, Geier A, Tuthill T, Brosnan MJ, Anstee QM, Neubauer S, Harrison SA, Bossuyt PM, Pavlides M; LITMUS Investigators. Mózes FE, et al. Among authors: ziol m. Gut. 2022 May;71(5):1006-1019. doi: 10.1136/gutjnl-2021-324243. Epub 2021 May 17. Gut. 2022. PMID: 34001645 Free PMC article.
Real-World Outcomes of Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF Cohort.
Allaire M, Thiam EM, Amaddeo G, Bouattour M, Edeline J, Brusset B, Ziol M, Merle P, Blanc JF, Uguen T, Ganne N, Cattan S, Riachi G, Loustaud-Ratti V, Decaens T, Silvain C, Peron JM, Baron A, Pageaux GP, Oberti F, Anty R, Pascale A, Manfredi S, Bourliere M, Nousbaum JB, Heurgue A, Ollivier-Hourmand I, Lequoy M, Bronowicki JP, Villing AL, Ducournau G, Ganry O, Costentin C, Nguyen-Khac E. Allaire M, et al. Among authors: ziol m. Liver Int. 2025 Oct;45(10):e70337. doi: 10.1111/liv.70337. Liver Int. 2025. PMID: 40905621 Free PMC article.
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.
Zeng Q, Klein C, Caruso S, Maille P, Allende DS, Mínguez B, Iavarone M, Ningarhari M, Casadei-Gardini A, Pedica F, Rimini M, Perbellini R, Boulagnon-Rombi C, Heurgué A, Maggioni M, Rela M, Vij M, Baulande S, Legoix P, Lameiras S; HCC-AI study group; Bruges L, Gnemmi V, Nault JC, Campani C, Rhee H, Park YN, Iñarrairaegui M, Garcia-Porrero G, Argemi J, Sangro B, D'Alessio A, Scheiner B, Pinato DJ, Pinter M, Paradis V, Beaufrère A, Peter S, Rimassa L, Di Tommaso L, Vogel A, Michalak S, Boursier J, Loménie N, Ziol M, Calderaro J. Zeng Q, et al. Among authors: ziol m. Lancet Oncol. 2023 Dec;24(12):1411-1422. doi: 10.1016/S1470-2045(23)00468-0. Epub 2023 Nov 8. Lancet Oncol. 2023. PMID: 37951222
Integrated genomic analyses identify oncogenic pathway interplay in hepatocarcinogenesis defining specific molecular subtypes.
Pan L, Hirsch TZ, Fang J, Seretny A, Imbeaud S, Jin S, Gege OO, Rebouissou S, Sidali S, Ammiche N, Calderaro J, Amaddeo G, Blanc JF, Le Bail B, Ziol M, Celton-Morizur S, Paradis V, Llovet JM, Tschaharganeh DF, Nault JC, Desdouets C, Caruso S, Zucman-Rossi J. Pan L, et al. Among authors: ziol m. Nat Commun. 2026 May 19;17(1):6598. doi: 10.1038/s41467-026-73212-y. Nat Commun. 2026. PMID: 42156413 Free PMC article.
MASLD-related HCC: Multicenter study comparing patients with and without cirrhosis.
Vitellius C, Desjonqueres E, Lequoy M, Amaddeo G, Fouchard I, N'Kontchou G, Canivet CM, Ziol M, Regnault H, Lannes A, Oberti F, Boursier J, Ganne-Carrie N. Vitellius C, et al. Among authors: ziol m. JHEP Rep. 2024 Jun 29;6(10):101160. doi: 10.1016/j.jhepr.2024.101160. eCollection 2024 Oct. JHEP Rep. 2024. PMID: 39411648 Free PMC article.
Serum Procalcitonin: A Novel Tumor Biomarker for Diagnosis and Follow-Up in Fibrolamellar Hepatocellular Carcinoma.
Nault JC, Campani C, Hirsch TZ, Neumann E, Arif W, Imbeaud S, Baretti M, Ziol M, Sidali S, Roger P, Allaire M, Bouattour M, Marra F, Fresneau B, Llarch N, Peron JM, Gerolami R, Khac EN, Nahon P, Ganne-Carrié N, Caldéraro J, Beaufrère A, Paradis V, Guettier C; CAPRIH FFCD cohort; Sutton A, Yarchoan M, Zucman-Rossi J. Nault JC, et al. Among authors: ziol m. medRxiv [Preprint]. 2025 Nov 20:2025.11.18.25340286. doi: 10.1101/2025.11.18.25340286. medRxiv. 2025. Update in: J Hepatol. 2026 Jun;84(6):1121-1130. doi: 10.1016/j.jhep.2026.01.015. PMID: 41332840 Free PMC article. Updated. Preprint.
185 results